RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DE BONO JS
Collezione AOU San Luigi di Orbassano

Items : 3

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). in European urology / Eur Urol. 2025 Feb;87(2):157-216. doi: 10.1016/j.eururo.2024.09.017. Epub 2024 Oct 11.

2025
AOU San Luigi di Orbassano

Gillessen S; Turco F; Davis ID; Efstathiou JA; Fizazi K; James ND; Shore N; Small E; Smith M; Sweeney CJ; Tombal B; Zilli T; Agarwal N; Antonarakis ES; Aparicio A; Armstrong AJ; Bastos DA; Attard G; Axcrona K; Ayadi M; Beltran H; Bjartell A; Blanchard P; Bourlon MT; Briganti A; Bulbul M; Buttigliero C; Caffo O; Castellano D; et alii...

Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. in The oncologist / Oncologist. 2022 Oct 1;27(10):e783-e795. doi: 10.1093/oncolo/oyac172.

2022
AOU San Luigi di Orbassano

Mehra N; Fizazi K; de Bono JS; Barthélémy P; Dorff T; Stirling A; Machiels JP; Bimbatti D; Kilari D; Dumez H; Buttigliero C; van Oort IM; Castro E; Chen HC; Di Santo N; DeAnnuntis L; Healy CG; Scagliotti GV;

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10.

2021
AOU San Luigi di Orbassano

de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K;